Bausch + Lomb

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares were surging nearly 14 percent after the open Tuesday after the company reported first-quarter results and announced a name change to Bausch Health Companies Inc. that takes effect in July.  What Happened Canada-based Valeant said it...

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) announced on Monday that three senior executives will be leaving the company. The executives that will be leaving the company include: Valeant's ex CFO Rob Rosiello, who stepped down in August but remained with the company since. Ari...

Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) have appreciated 17.21 percent over the past three months, while declining 0.35 percent over the past month. Rodman & Renshaw’s Raghuram Selvaraju has initiated coverage of the company with a Buy rating and price target of $150...

U.S. stocks were lower as leaders from Britain, France, Germany and Canada have all made their respective countries position clear that Russia will face further sanctions if air investigators are not given full access to the crash site in Ukraine. Israel continued its ground offensive in the...